resorcinol has been researched along with Hidradenitis Suppurativa in 7 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
Hidradenitis Suppurativa: A chronic suppurative and cicatricial disease of the apocrine glands occurring chiefly in the axillae in women and in the groin and anal regions in men. It is characterized by poral occlusion with secondary bacterial infection, evolving into abscesses which eventually rupture. As the disease becomes chronic, ulcers appear, sinus tracts enlarge, fistulas develop, and fibrosis and scarring become evident.
Excerpt | Relevance | Reference |
---|---|---|
"Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration." | 8.12 | Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022) |
"Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS." | 7.76 | Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010) |
"Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration." | 4.12 | Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022) |
"Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS." | 3.76 | Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010) |
"Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition." | 2.55 | What is hidradenitis suppurativa? ( Alhusayen, R; Lansang, P; Lee, EY; Shear, N; Yeung, J, 2017) |
"The diagnosis of eruptive xanthoma (EX) was clinically confirmed." | 1.56 | Concomitant Hidradenitis Suppurativa and Eruptive Xanthomas Presenting with Phimosis - The Importance of Timely Diagnosis. ( Andersen, RK; Ernst Jemec, GB; Saunte, DM; Yazdanyar, S, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Riis, PT | 1 |
Saunte, DM | 2 |
Sigsgaard, V | 1 |
Villani, AP | 1 |
Guillem, P | 1 |
Pascual, JC | 2 |
Kappe, NN | 1 |
Vanlaerhoven, AMJD | 1 |
van der Zee, HH | 1 |
Prens, EP | 1 |
El-Domyati, M | 1 |
Abdel-Wahab, H | 1 |
Moftah, N | 1 |
Abdelghani, R | 1 |
Agut-Busquet, E | 1 |
Romaní, J | 1 |
Hlela, C | 1 |
van den Worm, L | 1 |
Bettoli, V | 1 |
Calamo, G | 1 |
Gürer, MA | 1 |
Beksaç, B | 1 |
Matusiak, L | 1 |
Glowaczewska, A | 1 |
Szepietowski, JC | 1 |
Emtestam, L | 1 |
Lapins, J | 1 |
Kottb, HR | 1 |
Fatani, M | 1 |
Weibel, L | 1 |
Theiler, M | 1 |
Delage-Toriel, M | 1 |
Lam, TTH | 1 |
Nassif, A | 1 |
Becherel, PA | 1 |
Dolenc-Voljc, M | 1 |
Doss, N | 1 |
Bouazzi, D | 1 |
Benhadou, F | 1 |
Del Marmol, V | 1 |
Jemec, GBE | 1 |
Cordero-Ramos, J | 1 |
Merino-Bohórquez, V | 1 |
Delgado-Valverde, M | 1 |
Barros-Tornay, R | 1 |
Cameán-Fenández, M | 1 |
Calleja-Hernández, MÁ | 1 |
Andersen, RK | 1 |
Yazdanyar, S | 1 |
Ernst Jemec, GB | 1 |
Encabo, B | 1 |
Ruiz de Apodaca, RF | 1 |
Romero, D | 1 |
Selva, J | 1 |
Jemec, GB | 2 |
Alavi, A | 1 |
Kirsner, RS | 1 |
Lee, EY | 1 |
Alhusayen, R | 1 |
Lansang, P | 1 |
Shear, N | 1 |
Yeung, J | 1 |
Boer, J | 1 |
2 reviews available for resorcinol and Hidradenitis Suppurativa
Article | Year |
---|---|
Local wound care and topical management of hidradenitis suppurativa.
Topics: Administration, Cutaneous; Adult; Anti-Infective Agents, Local; Clindamycin; Combined Modality Thera | 2015 |
What is hidradenitis suppurativa?
Topics: Anti-Bacterial Agents; Biological Products; Hidradenitis Suppurativa; Hormones; Humans; Immunosuppre | 2017 |
1 trial available for resorcinol and Hidradenitis Suppurativa
Article | Year |
---|---|
Topical 15% resorcinol for hidradenitis suppurativa: An uncontrolled prospective trial with clinical and ultrasonographic follow-up.
Topics: Administration, Topical; Adolescent; Adult; Aged; Female; Follow-Up Studies; Hidradenitis Suppurativ | 2017 |
4 other studies available for resorcinol and Hidradenitis Suppurativa
Article | Year |
---|---|
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Anti-Bacterial Agents; B | 2020 |
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
Topics: Aluminum; Amber; Chemical Phenomena; Drug Stability; Emulsions; Hidradenitis Suppurativa; Humans; Pa | 2022 |
Concomitant Hidradenitis Suppurativa and Eruptive Xanthomas Presenting with Phimosis - The Importance of Timely Diagnosis.
Topics: Delayed Diagnosis; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Hidradenitis | 2020 |
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.
Topics: Adult; Drug Administration Schedule; Female; Hidradenitis Suppurativa; Humans; Middle Aged; Pain; Pa | 2010 |